| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new key-player for onchocerciasis elimination
|
Jesudason, Timothy
|
|
|
23 |
4 |
p. 413
|
artikel
|
| 2 |
An opportunity seized: rapid clinical research provides insights into monkeypox virus dynamics and durations of infectiousness
|
Dunning, Jake
|
|
|
23 |
4 |
p. 383-385
|
artikel
|
| 3 |
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
|
Uraki, Ryuta
|
|
|
23 |
4 |
p. 402-403
|
artikel
|
| 4 |
Being ready for the next influenza pandemic?
|
Kuiken, Thijs
|
|
|
23 |
4 |
p. 398-399
|
artikel
|
| 5 |
ChatGPT and antimicrobial advice: the end of the consulting infection doctor?
|
Howard, Alex
|
|
|
23 |
4 |
p. 405-406
|
artikel
|
| 6 |
Cholera outbreak in Africa
|
Nakkazi, Esther
|
|
|
23 |
4 |
p. 411
|
artikel
|
| 7 |
Clade IIb A.3 monkeypox virus: an imported lineage during a large global outbreak
|
Woolley, Stephen D
|
|
|
23 |
4 |
p. 405
|
artikel
|
| 8 |
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
|
Domínguez, José
|
|
|
23 |
4 |
p. e122-e137
|
artikel
|
| 9 |
Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
|
Irving, Stephanie A
|
|
|
23 |
4 |
p. 382-383
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2022; published online Dec 22. https://doi.org/10.1016/S1473-3099(22)00806-4
|
|
|
|
23 |
4 |
p. e121
|
artikel
|
| 11 |
CROI 2023
|
Mushtaq, Ammara
|
|
|
23 |
4 |
p. 412
|
artikel
|
| 12 |
Curing chronic hepatitis B virus infection
|
Hsu, Yao-Chun
|
|
|
23 |
4 |
p. 392-393
|
artikel
|
| 13 |
Diana Florescu
|
Bagcchi, Sanjeet
|
|
|
23 |
4 |
p. 417
|
artikel
|
| 14 |
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
|
Tsang, Nicole Ngai Yung
|
|
|
23 |
4 |
p. 421-434
|
artikel
|
| 15 |
Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial
|
Betu Kumeso, Victor Kande
|
|
|
23 |
4 |
p. 463-470
|
artikel
|
| 16 |
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
|
Tsalik, Ephraim L
|
|
|
23 |
4 |
p. 484-495
|
artikel
|
| 17 |
HIV vaccine trial failure
|
Venkatesan, Priya
|
|
|
23 |
4 |
p. 410
|
artikel
|
| 18 |
Infection rate in Guangzhou after easing the zero-COVID policy: seroprevalence results to ORF8 antigen
|
Huang, Junyuan
|
|
|
23 |
4 |
p. 403-404
|
artikel
|
| 19 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
23 |
4 |
p. 415
|
artikel
|
| 20 |
Luciano Moreira—battling arboviral diseases with ‘wolbitos’
|
Kirby, Tony
|
|
|
23 |
4 |
p. 418
|
artikel
|
| 21 |
Lupus vulgaris of the left breast
|
Chen, Tian
|
|
|
23 |
4 |
p. 508
|
artikel
|
| 22 |
Moving towards malaria elimination with safer treatment for children with G6PD deficiency
|
Boum, Yap
|
|
|
23 |
4 |
p. 388-390
|
artikel
|
| 23 |
NDM-9 resistance to taniborbactam
|
Le Terrier, Christophe
|
|
|
23 |
4 |
p. 401-402
|
artikel
|
| 24 |
On the importance and challenges of global access to proven life-saving treatments for Ebolavirus
|
Mbaya, Olivier Tshiani
|
|
|
23 |
4 |
p. 406-407
|
artikel
|
| 25 |
On the importance and challenges of global access to proven life-saving treatments for Ebolavirus – Authors' reply
|
Torreele, Els
|
|
|
23 |
4 |
p. 407-408
|
artikel
|
| 26 |
Overcoming stigma—contracting mpox as a minoritised trainee
|
Irshad, Usama
|
|
|
23 |
4 |
p. 400
|
artikel
|
| 27 |
Pandemic policy and the ethics of elimination
|
Jamrozik, Euzebiusz
|
|
|
23 |
4 |
p. 420
|
artikel
|
| 28 |
Post-tuberculosis sequelae in children and adolescents: a systematic review
|
Igbokwe, Vanessa
|
|
|
23 |
4 |
p. e138-e150
|
artikel
|
| 29 |
Procalcitonin to reduce antimicrobial overuse in patients with lower respiratory tract infection: time for re-evaluation of our prescription culture?
|
Sivapalan, Pradeesh
|
|
|
23 |
4 |
p. 390-391
|
artikel
|
| 30 |
Promoting diversity and equity in publishing
|
The Lancet Infectious Diseases,
|
|
|
23 |
4 |
p. 381
|
artikel
|
| 31 |
Protecting pregnant women in an Ebola outbreak
|
Burki, Talha
|
|
|
23 |
4 |
p. 419
|
artikel
|
| 32 |
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control study
|
Powell, Annabel A
|
|
|
23 |
4 |
p. 435-444
|
artikel
|
| 33 |
Research in brief
|
Devi, Sharmila
|
|
|
23 |
4 |
p. 416
|
artikel
|
| 34 |
Role of immunity landscape in global risk assessment of re-emerging diseases
|
Pandey, Abhishek
|
|
|
23 |
4 |
p. 385-386
|
artikel
|
| 35 |
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
|
Taylor, Walter R
|
|
|
23 |
4 |
p. 471-483
|
artikel
|
| 36 |
Sleeping sickness: time for dreaming
|
Pépin, Jacques
|
|
|
23 |
4 |
p. 387-388
|
artikel
|
| 37 |
South Sudan tackles measles outbreaks
|
Bagcchi, Sanjeet
|
|
|
23 |
4 |
p. 409
|
artikel
|
| 38 |
Successful use of interferon alfa-2a for persistent parvovirus B19 infection
|
Mogensen, Trine H
|
|
|
23 |
4 |
p. e160-e165
|
artikel
|
| 39 |
Suffering on top of suffering
|
Burki, Talha
|
|
|
23 |
4 |
p. 414-415
|
artikel
|
| 40 |
The global landscape of smallpox vaccination history and implications for current and future orthopoxvirus susceptibility: a modelling study
|
Taube, Juliana C
|
|
|
23 |
4 |
p. 454-462
|
artikel
|
| 41 |
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial
|
Yuen, Man-Fung
|
|
|
23 |
4 |
p. 496-507
|
artikel
|
| 42 |
Treatment and prevention of mpox in pregnant people and young children
|
Khalil, Asma
|
|
|
23 |
4 |
p. 396-397
|
artikel
|
| 43 |
Understanding clinical outcome measures reported in HIV pregnancy studies involving antiretroviral-naive and antiretroviral-experienced women
|
Eke, Ahizechukwu C
|
|
|
23 |
4 |
p. e151-e159
|
artikel
|
| 44 |
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain
|
Suñer, Clara
|
|
|
23 |
4 |
p. 445-453
|
artikel
|
| 45 |
Why we need a deeper understanding of the pathophysiology of long COVID
|
Iwasaki, Akiko
|
|
|
23 |
4 |
p. 393-395
|
artikel
|
Tijdschrift beschrijving